Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Legha

Showing results (11-20 of 179) with videos related to

Pageof 18
Sort By:
The New England Journal of Medicine|May 18, 1995
Idiopathic dilated cardiomyopathyS S Legha
Seminars in Oncology|February 1, 1989
Current therapy for malignant melanomaS S Legha
Seminars in Oncology|February 1, 1997
Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon alpha and chemotherapyS S Legha
Annals of Internal Medicine|June 1, 1976
Letter: Antiestrogens in the treatment of cancerS Legha, F M Muggia
Cancer Treatment Reports|January 1, 1978
Acute cyclophosphamide hypersensitivity reaction: possible lack of cross-sensitivity to mechlorethamine and isophosphamideS S Legha, S Hall
Cancer Treatment Reviews|March 1, 1977
Therapeutic approaches in malignant mesotheliomaS S Legha, F M Muggia
Seminars in Oncology|December 1, 1994
Combination of chemotherapy with interleukin-2 and interferon-alfa for the treatment of advanced melanomaA C Buzaid, S S Legha
Annals of Internal Medicine|October 1, 1981
Doxorubicin toxicityS S Legha, R S Benjamin
Cancer Treatment Reviews|December 1, 1976
Antiestrogens in the treatment of breast cancerS S Legha, S K Carter
Melanoma Research|April 20, 2004
Phase II study of thalidomide in patients with metastatic melanomaWojciech Z Pawlak, Sewa S Legha
Pageof 18

Showing results (11-20 of 179) with videos related to

Sort By:
Pageof 18
The New England Journal of Medicine|May 18, 1995
Idiopathic dilated cardiomyopathyS S Legha
Seminars in Oncology|February 1, 1989
Current therapy for malignant melanomaS S Legha
Seminars in Oncology|February 1, 1997
Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon alpha and chemotherapyS S Legha
Annals of Internal Medicine|June 1, 1976
Letter: Antiestrogens in the treatment of cancerS Legha, F M Muggia
Cancer Treatment Reports|January 1, 1978
Acute cyclophosphamide hypersensitivity reaction: possible lack of cross-sensitivity to mechlorethamine and isophosphamideS S Legha, S Hall
Cancer Treatment Reviews|March 1, 1977
Therapeutic approaches in malignant mesotheliomaS S Legha, F M Muggia
Seminars in Oncology|December 1, 1994
Combination of chemotherapy with interleukin-2 and interferon-alfa for the treatment of advanced melanomaA C Buzaid, S S Legha
Annals of Internal Medicine|October 1, 1981
Doxorubicin toxicityS S Legha, R S Benjamin
Cancer Treatment Reviews|December 1, 1976
Antiestrogens in the treatment of breast cancerS S Legha, S K Carter
Melanoma Research|April 20, 2004
Phase II study of thalidomide in patients with metastatic melanomaWojciech Z Pawlak, Sewa S Legha
Pageof 18